SWM
JNJ icon

Salvus Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Salvus Wealth Management’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.02M Sell
7,937
-152
-2% -$35.4K 1.13% 28
2026
Q1 		$1.98M Buy
8,089
+83
+1% +$19.3K 1.15% 25
2025
Q4 		$1.66M Buy
8,006
+142
+2% +$28.1K 0.93% 31
2025
Q3 		$1.46M Buy
7,864
+412
+6% +$70.6K 0.81% 33
2025
Q2 		$1.14M Buy
7,452
+61
+0.8% +$9.38K 0.66% 43
2025
Q1 		$1.23M Buy
7,391
+1,093
+17% +$171K 0.77% 37
2024
Q4 		$911K Sell
6,298
-201
-3% -$31.1K 0.58% 48
2024
Q3 		$1.05M Buy
6,499
+138
+2% +$22K 0.65% 42
2024
Q2 		$930K Sell
6,361
-264
-4% -$39.3K 0.64% 43
2024
Q1 		$1.05M Buy
6,625
+10
+0.2% +$1.59K 0.72% 37
2023
Q4 		$1.04M Sell
6,615
-36
-0.5% -$5.52K 0.74% 32
2023
Q3 		$1.04M Buy
6,651
+104
+2% +$17.2K 0.82% 31
2023
Q2 		$1.08M Buy
6,547
+388
+6% +$62.6K 0.83% 30
2023
Q1 		$955K Buy
6,159
+43
+0.7% +$6.94K 0.77% 34
2022
Q4 		$1.08M Buy
6,116
+6
+0.1% +$1.04K 0.99% 27
2022
Q3 		$998K Buy
6,110
+251
+4% +$42.5K 0.95% 28
2022
Q2 		$1.04M Sell
5,859
-17
-0.3% -$3.03K 0.93% 29
2022
Q1 		$1.04M Buy
5,876
+157
+3% +$26.7K 0.8% 33
2021
Q4 		$978K Buy
5,719
+158
+3% +$25.9K 0.71% 37
2021
Q3 		$898K Buy
5,561
+308
+6% +$52.5K 0.73% 32
2021
Q2 		$872K Buy
5,253
+685
+15% +$113K 0.74% 32
2021
Q1 		$744K Buy
4,568
+707
+18% +$114K 0.7% 35
2020
Q4 		$618K Buy
+3,861
New +$570K 0.67% 37

Other funds holding JNJ

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Salvus Wealth Management's JNJ Position: Q2 2026 in Review

Salvus Wealth Management reduced its Johnson & Johnson (JNJ) stake by 1.9% in Q2 2026, selling an estimated $35.4K and leaving 7,937 shares worth $2.02M. The position accounts for 1.13% of the portfolio, ranked #28.

Salvus Wealth Management first reported a position in JNJ in Q4 2020 and has held it in 23 quarters since. 899 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Salvus Wealth Management held 7,937 shares of Johnson & Johnson worth $2.02M as of Q2 2026.
  • Salvus Wealth Management sold 152 Johnson & Johnson shares in Q2 2026, an estimated $35.4K.
  • Johnson & Johnson made up 1.13% of Salvus Wealth Management's portfolio in Q2 2026, its #28 holding.
  • Salvus Wealth Management first reported a position in Johnson & Johnson in Q4 2020 and has held it in 23 quarters since.
  • 899 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Salvus Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.